New York, NY -- (SBWIRE) -- 01/15/2014 -- King Penny Stocks is an elite financial community for investors and traders alike who are looking to potentially gain financial freedom through the markets on undervalued companies and “in-play” momentum penny stocks. Today we bring special trend analysis of following stocks: JinkoSolar Holding Co., Ltd. (NYSE:JKS), Ambarella Inc (NASDAQ:AMBA), ImmunoGen, Inc. (NASDAQ:IMGN), BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX).
PLUS you’ll get KingPennyStock’s Pro Trading Rules Mini E-book absolutely FREE! Claim Your Copy
JinkoSolar Holding Co., Ltd. (NYSE:JKS) stock moved up 9.38% and finished the day at $36.25, while its opening price was $33.63. The company traded with the total volume of 2.73 million shares, while its average trading volume remained 1.80 million shares. During the last one month it rose with the percentage of 39.53. JinkoSolar Holding Co., Ltd., together with its subsidiaries, engages in designing, developing, producing, and marketing photovoltaic products in the People’s Republic of China and internationally.
For How Long JKS will fight for Profitability? Read This Trend Analysis report
Ambarella Inc (NASDAQ:AMBA) percentage change mounted 9.38% to close at $31.71 with the total traded volume of 2.54 million shares, and average volume of 1.66 million. The Company’s year to date performance remained pessimistic with the fall of -6.43%. During last trade its minimum price was $29.60 and it gained its highest price of $32.40. Ambarella, Inc. develops semiconductor processing solutions for video that enable high-definition (HD) video capture, sharing, and display.
Will AMBA Continue To Move Higher? Find Out Here
ImmunoGen, Inc. (NASDAQ:IMGN) started its trading session with the price of $14.75 and closed at $15.95 by scoring 8.87%. The stocks traded with total volume of 1.19 million shares, while the average trading volume remained 691,484.00 shares. Previous 5 days graph demonstrated a positive move of 9.1%. The 52-week price range of the stock remained $12.55 - $20.25. ImmunoGen, Inc., a biotechnology company, develops targeted anticancer therapeutics. The company develops its products using its targeted antibody payload technology.
Why Should Investors Buy IMGN After The Recent Gain? Just Go Here and Find Out
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) during the previous trading session, the stock showed a positive movement of 8.56%. BCRX traded with volume of 2.41 million shares, while its average trading volume remained 1.15 million shares. Stock’s closing price was $11.41 while it started its day-trade at $10.45. Its 52-week price range was $1.12 - $11.62. BioCryst Pharmaceuticals, Inc., a biotechnology company, designs, optimizes, and develops novel drugs that block key enzymes involved in the pathogenesis of diseases.
Will BCRX Continue To Move Higher? Find Out Here
About King Penny Stocks
King Penny Stocks provides up to the minute dissemination of news while reporting on stocks that are actively traded in the small cap arena whether trading on the Nasdaq small caps, AMEX or the OTC markets. Since performance is key in our industry, it’s no wonder why our ground breaking alerts on active stocks have brought us to the forefront of this industry. Our due diligence on trend analysis has caught the attention of the very best chart technicians in the business.
King Penny Stocks is an elite financial community for investors and traders alike who are looking to potentially gain financial freedom through the markets on undervalued companies and “in-play” momentum penny stocks. Get detailed breakdowns of major trends impacting the markets?
Our newsletter, Press Release and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company.
An individual should never invest in the securities of any of the company’s profiled based solely on information contained in our report. Individuals should assume that all information contained in the report about profiled companies is not trustworthy unless verified by their own independent research. This report/release/advertisement is a commercial advertisement and is for general information purposes only. We are engaged in the business of marketing and advertising companies for monetary compensation.
Read our Full Disclaimer at: http://kingpennystocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)